BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 35940258)

  • 1. AMPKα2/HNF4A/BORIS/GLUT4 pathway promotes hepatocellular carcinoma cell invasion and metastasis in low glucose microenviroment.
    Huang Y; Xian L; Liu Z; Wei L; Qin L; Xiong Y; Hu L; Zhou S; Fu Q; Li B; Qin Y
    Biochem Pharmacol; 2022 Sep; 203():115198. PubMed ID: 35940258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ras Homolog Family Member F, Filopodia Associated Promotes Hepatocellular Carcinoma Metastasis by Altering the Metabolic Status of Cancer Cells Through RAB3D.
    Li S; Liu Y; Bai Y; Chen M; Cheng D; Wu M; Xia J
    Hepatology; 2021 Jun; 73(6):2361-2379. PubMed ID: 33205519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BORIS, brother of the regulator of imprinted sites, is aberrantly expressed in hepatocellular carcinoma.
    Chen K; Huang W; Huang B; Wei Y; Li B; Ge Y; Qin Y
    Genet Test Mol Biomarkers; 2013 Feb; 17(2):160-5. PubMed ID: 23237599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [BORIS Regulates SOCS3 Expression Through Epigenetic Mechanisms in Human Hepatocellular Carcinoma Cells].
    He JY; Liu QY; Wei L; Liu ZJ; Huang Y; Yu XQ; Li B; Qin Y
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2018 Jan; 49(1):1-7. PubMed ID: 29737080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Jun/Fos promotes migration and invasion of hepatocellular carcinoma cells by enhancing BORIS promoter activity.
    Xian L; Xiong Y; Qin L; Wei L; Zhou S; Wang Q; Fu Q; Chen M; Qin Y
    Int J Biochem Cell Biol; 2024 Apr; 169():106540. PubMed ID: 38281696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. UBE2O promotes hepatocellular carcinoma cell proliferation and invasion by regulating the AMPKα2/mTOR pathway.
    Shi Z; Liu R; Lu Q; Zeng Z; Liu Y; Zhao J; Liu X; Li L; Huang H; Yao Y; Huang D; Xu Q
    Int J Med Sci; 2021; 18(16):3749-3758. PubMed ID: 34790050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PCK1 negatively regulates cell cycle progression and hepatoma cell proliferation via the AMPK/p27
    Tuo L; Xiang J; Pan X; Hu J; Tang H; Liang L; Xia J; Hu Y; Zhang W; Huang A; Wang K; Tang N
    J Exp Clin Cancer Res; 2019 Feb; 38(1):50. PubMed ID: 30717766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HSP90 promotes cell glycolysis, proliferation and inhibits apoptosis by regulating PKM2 abundance via Thr-328 phosphorylation in hepatocellular carcinoma.
    Xu Q; Tu J; Dou C; Zhang J; Yang L; Liu X; Lei K; Liu Z; Wang Y; Li L; Bao H; Wang J; Tu K
    Mol Cancer; 2017 Dec; 16(1):178. PubMed ID: 29262861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BORIS up-regulates OCT4 via histone methylation to promote cancer stem cell-like properties in human liver cancer cells.
    Liu Q; Chen K; Liu Z; Huang Y; Zhao R; Wei L; Yu X; He J; Liu J; Qi J; Qin Y; Li B
    Cancer Lett; 2017 Sep; 403():165-174. PubMed ID: 28645561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucose transporter 4 promotes head and neck squamous cell carcinoma metastasis through the TRIM24-DDX58 axis.
    Chang YC; Chi LH; Chang WM; Su CY; Lin YF; Chen CL; Chen MH; Chang PM; Wu AT; Hsiao M
    J Hematol Oncol; 2017 Jan; 10(1):11. PubMed ID: 28061796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FOXC1 promotes HCC proliferation and metastasis by Upregulating DNMT3B to induce DNA Hypermethylation of CTH promoter.
    Lin Z; Huang W; He Q; Li D; Wang Z; Feng Y; Liu D; Zhang T; Wang Y; Xie M; Ji X; Sun M; Tian D; Xia L
    J Exp Clin Cancer Res; 2021 Feb; 40(1):50. PubMed ID: 33522955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caveolin-1 promotes Rfng expression via Erk-Jnk-p38 signaling pathway in mouse hepatocarcinoma cells.
    Zhang C; Wu Q; Huang H; Chen X; Huang T; Li W; Liu Y; Zhang J
    J Physiol Biochem; 2019 Nov; 75(4):549-559. PubMed ID: 31529314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intragenic DNA methylation and BORIS-mediated cancer-specific splicing contribute to the Warburg effect.
    Singh S; Narayanan SP; Biswas K; Gupta A; Ahuja N; Yadav S; Panday RK; Samaiya A; Sharan SK; Shukla S
    Proc Natl Acad Sci U S A; 2017 Oct; 114(43):11440-11445. PubMed ID: 29073069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MEF2A binding to the Glut4 promoter occurs via an AMPKα2-dependent mechanism.
    Gong H; Xie J; Zhang N; Yao L; Zhang Y
    Med Sci Sports Exerc; 2011 Aug; 43(8):1441-50. PubMed ID: 21233771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TRIB1 is a positive regulator of hepatocyte nuclear factor 4-alpha.
    Soubeyrand S; Martinuk A; McPherson R
    Sci Rep; 2017 Jul; 7(1):5574. PubMed ID: 28717196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulated FoxM1 expression induced by hepatitis B virus X protein promotes tumor metastasis and indicates poor prognosis in hepatitis B virus-related hepatocellular carcinoma.
    Xia L; Huang W; Tian D; Zhu H; Zhang Y; Hu H; Fan D; Nie Y; Wu K
    J Hepatol; 2012 Sep; 57(3):600-12. PubMed ID: 22613004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic role of BORIS and SOCS3 in human hepatocellular carcinoma.
    Zhao R; Chen K; Zhou J; He J; Liu J; Guan P; Li B; Qin Y
    Medicine (Baltimore); 2017 Mar; 96(12):e6420. PubMed ID: 28328845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIF-1α promoted vasculogenic mimicry formation in hepatocellular carcinoma through LOXL2 up-regulation in hypoxic tumor microenvironment.
    Wang M; Zhao X; Zhu D; Liu T; Liang X; Liu F; Zhang Y; Dong X; Sun B
    J Exp Clin Cancer Res; 2017 Apr; 36(1):60. PubMed ID: 28449718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LINC01554-Mediated Glucose Metabolism Reprogramming Suppresses Tumorigenicity in Hepatocellular Carcinoma via Downregulating PKM2 Expression and Inhibiting Akt/mTOR Signaling Pathway.
    Zheng YL; Li L; Jia YX; Zhang BZ; Li JC; Zhu YH; Li MQ; He JZ; Zeng TT; Ban XJ; Yuan YF; Li Y; Guan XY
    Theranostics; 2019; 9(3):796-810. PubMed ID: 30809309
    [No Abstract]   [Full Text] [Related]  

  • 20. RRAD inhibits aerobic glycolysis, invasion, and migration and is associated with poor prognosis in hepatocellular carcinoma.
    Shang R; Wang J; Sun W; Dai B; Ruan B; Zhang Z; Yang X; Gao Y; Qu S; Lv X; Tao K; Wang L; Dou K; Wang D
    Tumour Biol; 2016 Apr; 37(4):5097-105. PubMed ID: 26546438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.